To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Lymphoma Cancer

Katie Kosko
The Food and Drug Administration granted CLR 131, a targeted, molecular radiotherapy, a fast track designation.
Katie Kosko
A lymphoma expert discusses the side effect profile and follow-up data from the ECHELON-1 clinical trial.
Tamera Anderson-Hanna
Women who undergo a mastectomy have many options and concerns to consider when undergoing breast reconstruction. My choice was simple: I wanted to look as natural as possible, but I have since learned that I have textured implants.
Alyssa Castro
When I was diagnosed with Hodgkin's lymphoma, I envisioned myself in a galaxy far, far away. Just like any well-trained Jedi, I fought back when insurance denied my claim for doctor-recommended treatment.
Ryan Hamner
Here are three things I learned to avoid when recovering from cancer treatment.
Jason M. Broderick
The FDA has granted an accelerated approval to Polivy for use in combination with bendamustine and Rituxan for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma who have received at least two prior therapies.
Ryan Hamner
Having hope in the now is really faith in the future.
Jason M. Broderick
The Food and Drug Administration has approved the combination regimen of Revlimid plus Rituxan for use in patients with previously-treated follicular lymphoma and marginal zone lymphoma.
Alexandra Guadagno
The FDA has approved Jakafi, the first and only treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients aged 12 years and older.
Alexandra Guadagno
From World Blood Cancer Day to today’s top performers fundraising for lifesaving research, here’s what’s making headlines in the cancer space this week.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other